Robert H. Rosen is on the board of La Jolla Pharmaceutical Co. and Odonate Therapeutics, Inc. Mr. Rosen previously held the position of President & Director at Heron Therapeutics, Inc., Managing Partner at Scotia Nordic LLC, Senior VP-Global Commercial Operations at Dendreon Corp., Global Head-Oncology at Bayer HealthCare Pharmaceuticals, Inc. and Vice President-Oncology Business Unit at Sanofi-Synthelabo, Inc.

Mr. Rosen received an undergraduate degree from Northeastern University.